Malcolm McColl, Founder of ImmVirX

Malcolm McColl is the founder of ImmVirX. ImmVirX has raised $47M in total funding. Latest round: Series B. Backed by One Ventures, Acorn Capital.

About Malcolm McColl

Malcolm McColl is the CEO and Co-Founder of ImmVirX, a clinical-stage biotech company focused on developing receptor-targeted oncolytic RNA immunotherapies for cancer. He brings experience from his previous work at Viralytics, which was acquired by Merck, and has a background in immunology.

Malcolm McColl at a glance

More founders in New Lambton Heights, NSW, Australia (44)

Browse related founder lists (4)

Full founder directory · Investor directory · Company funding database · Fundraising library